Tag: Vaccines
COVID-19 Vaccine Protection Lasts at Least Six Months After Second Dose
Vaccine effectiveness against death was lower for patients aged 80 years and older
COVID-19 Vaccine Primary Series Coverage 76 Percent in Adults 60 Years and Older
Primary series coverage by end of 2022 was below the 100 percent target set for at-risk populations
mRNA COVID-19 Vaccines Not Tied to Increases in Guillain-Barré Syndrome
However, the Janssen COVID-19 vaccine was associated with increased risk at 21 and 42 days postvaccination
4CMenB Vaccination Effective Against Invasive Meningococcal Disease in Children Under 5
Vaccine effectiveness with at least one dose was 64 percent against serogroup B, 82 percent against non-serogroup B disease
Breast Milk of Vaccinated Moms Provides COVID-19 Protection to Infants
With maternal vaccination, SARS-CoV-2-specific IgA and IgG levels detected in infant stool through six months
Booster Cuts COVID-19-Related Mortality in Adults With Chronic Conditions
For adults with two or more chronic conditions, booster dose of BNT162b2 or CoronaVac linked to reduction in mortality
Updated Booster Shots, Not Original COVID-19 Vaccines, Should Be Standard: FDA Panel
Committee members also weighed a proposal to streamline the dosing schedule for COVID-19 vaccines by turning them into annual shots
Bivalent Vaccine Provides Added Protection Against BA.5, XBB/XBB.1.5
Additional protection against symptomatic infection provided for people who had previously received monovalent vaccine doses
Uptake Low for COVID-19 Vaccine Boosters in Immunocompromised Adults
Authors found low adherence to CDC recommendations for boosters, with older adults more likely to receive at least four mRNA COVID-19 vaccine doses
U.S. Proposes to Make COVID-19 Shot Annual, Much Like Flu Shot
FDA also wants to switch all COVID-19 vaccines to target the same strains, making the shots interchangeable and simpler to administer